1. Randomized Phase III Trial of Pegfilgrastim versus Filgrastim after Autologus Peripheral Blood Stem Cell Transplantation 
Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, Patrick Stiff 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 5, Pages (May 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Patient enrollment and movement through the study.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Neutrophil engraftment after transplant. Kaplain-Meier plot of time to an ANC of 1.5×109/L for 3 days, or 5×109/L for 1 day in the filgrastim group compared to the pegfilgrastim group.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Platelet count (×109/L) in the first 25 days after transplant.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Kaplan-Meier plot of OS in the in the filgrastim and pegfilgrastim groups.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions